AAAAAA
Results:
1-12
|
Results: 12
Authors:
DEVANE CL
HILL M
ANTAL EJ
Citation: Cl. Devane et al., THERAPEUTIC DRUG-MONITORING OF ALPRAZOLAM IN ADOLESCENTS WITH ASTHMA, Therapeutic drug monitoring, 20(3), 1998, pp. 257-260
Authors:
WRIGHT CE
SISSON TL
FLEISHAKER JC
ANTAL EJ
Citation: Ce. Wright et al., PHARMACOKINETICS AND PSYCHOMOTOR PERFORMANCE OF ALPRAZOLAM - CONCENTRATION-EFFECT RELATIONSHIP, Journal of clinical pharmacology, 37(4), 1997, pp. 321-329
Authors:
JABER LA
ANTAL EJ
WELSHMAN IR
Citation: La. Jaber et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF GLYBURIDE IN YOUNG AND ELDERLY PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, The Annals of pharmacotherapy, 30(5), 1996, pp. 472-475
Authors:
KUBACKA RT
ANTAL EJ
JUHL RP
WELSHMAN IR
Citation: Rt. Kubacka et al., EFFECTS OF ASPIRIN AND IBUPROFEN ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF GLYBURIDE IN HEALTHY-SUBJECTS, The Annals of pharmacotherapy, 30(1), 1996, pp. 20-26
Authors:
HUGHES GS
FRANCOM SF
ANTAL EJ
ADAMS WJ
LOCKER PK
YANCEY EP
JACOBS EE
Citation: Gs. Hughes et al., EFFECTS OF A NOVEL HEMOGLOBIN-BASED OXYGEN CARRIER ON PERCENT OXYGEN-SATURATION AS DETERMINED WITH ARTERIAL BLOOD-GAS ANALYSIS AND PULSE OXIMETRY, Annals of emergency medicine, 27(2), 1996, pp. 164-169
Authors:
HUGHES GS
ANTAL EJ
LOCKER PK
FRANCOM SF
ADAMS WJ
JACOBS EE
Citation: Gs. Hughes et al., PHYSIOLOGY AND PHARMACOKINETICS OF A NOVEL HEMOGLOBIN-BASED OXYGEN CARRIER IN HUMANS, Critical care medicine, 24(5), 1996, pp. 756-764
Authors:
HUGHES GS
FRANCOM SF
ANTAL EJ
ADAMS WJ
LOCKER PK
YANCEY EP
JACOBS EE
Citation: Gs. Hughes et al., HEMATOLOGIC EFFECTS OF A NOVEL HEMOGLOBIN-BASED OXYGEN CARRIER IN NORMAL-MALE AND FEMALE SUBJECTS, The Journal of laboratory and clinical medicine, 126(5), 1995, pp. 444-451
Authors:
HUGHES GS
YANCEY EP
ALBRECHT R
LOCKER PK
FRANCOM SF
ORRINGER EP
ANTAL EJ
JACOBS EE
Citation: Gs. Hughes et al., HEMOGLOBIN-BASED OXYGEN CARRIER PRESERVES SUBMAXIMAL EXERCISE CAPACITY IN HUMANS, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 434-443
Authors:
JABER LA
ANTAL EJ
SLAUGHTER RL
WELSHMAN IR
Citation: La. Jaber et al., COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF SHORT-TERM ANDLONG-TERM GLYBURIDE THERAPY IN NIDDM, Diabetes care, 17(11), 1994, pp. 1300-1306
Authors:
JABER LA
ANTAL EJ
SLAUGHTER RL
WELSHMAN IR
Citation: La. Jaber et al., COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF SHORT-TERM ANDLONG-TERM GLYBURIDE THERAPY IN NIDDM, Diabetes care, 17(11), 1994, pp. 1300-1306
Authors:
JABER LA
ANTAL EJ
SLAUGHTER RL
WELSHMAN IR
Citation: La. Jaber et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF 12 WEEKS OF GLYBURIDE THERAPY IN OBESE DIABETICS, European Journal of Clinical Pharmacology, 45(5), 1993, pp. 459-463
Authors:
DEVANE CL
GRASELA TH
ANTAL EJ
MILLER RL
Citation: Cl. Devane et al., EVALUATION OF POPULATION PHARMACOKINETICS IN THERAPEUTIC TRIALS .4. APPLICATION TO POSTMARKETING SURVEILLANCE, Clinical pharmacology and therapeutics, 53(5), 1993, pp. 521-528
Risultati:
1-12
|